1. Home
  2. GMED vs TFX Comparison

GMED vs TFX Comparison

Compare GMED & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GMED
  • TFX
  • Stock Information
  • Founded
  • GMED 2003
  • TFX 1943
  • Country
  • GMED United States
  • TFX United States
  • Employees
  • GMED N/A
  • TFX N/A
  • Industry
  • GMED Medical/Dental Instruments
  • TFX Medical/Dental Instruments
  • Sector
  • GMED Health Care
  • TFX Health Care
  • Exchange
  • GMED Nasdaq
  • TFX Nasdaq
  • Market Cap
  • GMED N/A
  • TFX 6.0B
  • IPO Year
  • GMED 2012
  • TFX N/A
  • Fundamental
  • Price
  • GMED $71.01
  • TFX $129.48
  • Analyst Decision
  • GMED Buy
  • TFX Hold
  • Analyst Count
  • GMED 13
  • TFX 10
  • Target Price
  • GMED $96.91
  • TFX $192.75
  • AVG Volume (30 Days)
  • GMED 1.3M
  • TFX 1.6M
  • Earning Date
  • GMED 05-08-2025
  • TFX 05-01-2025
  • Dividend Yield
  • GMED N/A
  • TFX 1.05%
  • EPS Growth
  • GMED N/A
  • TFX N/A
  • EPS
  • GMED 0.75
  • TFX 1.48
  • Revenue
  • GMED $2,519,355,000.00
  • TFX $3,047,324,000.00
  • Revenue This Year
  • GMED $8.52
  • TFX $1.40
  • Revenue Next Year
  • GMED $6.73
  • TFX $4.85
  • P/E Ratio
  • GMED $94.68
  • TFX $86.90
  • Revenue Growth
  • GMED 60.62
  • TFX 2.45
  • 52 Week Low
  • GMED $49.33
  • TFX $124.66
  • 52 Week High
  • GMED $94.93
  • TFX $249.91
  • Technical
  • Relative Strength Index (RSI)
  • GMED 43.99
  • TFX 38.95
  • Support Level
  • GMED $70.34
  • TFX $126.36
  • Resistance Level
  • GMED $74.34
  • TFX $132.51
  • Average True Range (ATR)
  • GMED 3.39
  • TFX 5.10
  • MACD
  • GMED 0.25
  • TFX 0.19
  • Stochastic Oscillator
  • GMED 53.31
  • TFX 27.94

About TFX Teleflex Incorporated

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.

Share on Social Networks: